Clinical Trials

  • Clinical Trials
  • NDA-Enabling Study Guide

    Altasciences' specialists apply their decades of experience in designing, conducting, analyzing, and reporting on trials for regulatory submissions, across the spectrum of therapeutic areas.

    Unclear as to which studies may be required?

    Download our complimentary fact sheet

    or click below to learn more about the requirements for each study type.

    Safety Tolerability and Pharmacokinetics of GIC-1001 Following Multiple Ascending Doses Administrations Through an Adaptive First-in-Human Study in Healthy Volunteers

    Cognitive Performance and Psychedelic Effects Following Single and Multiple Ascending Doses of a New Cannabis Formulation

    .custom-column-left-text { float: left; width: 50%; padding-right: 10px; } .custom-column-right-text { float: right; width: 45%; text-align:center; } @media only screen and (max-width: 600px) { .custom-column-left-text, .custom-column-right-text, .custom-column-flc-ebook-text { float:none; width:80%; margin:0 auto; } }

    Microsampling volume

    Blood microsampling is a less invasive and simplified alternative to traditional venipuncture, and provides significant ad

    Altasciences Fills Need of Leading Cancer Therapeutic Drug Developer

    Microsampling Benefits

    As an alternative to traditional venipuncture, blood microsampling represents a less invasive and simplified collection technique, resulting in numerous benefits for preclinical and clinical studies alike. Recent advances in device technology, specifically the Mitra® VAMS® microsampler manufactured by Neoteryx, has enabled Altasciences to fully support blood microsampling programs.

    With over 12 Mitra® VAMS® assays validated for a range of drug applications and study types, we look forward to sharing our combined expertise in support of your next microsampling program.

    Choosing the Right CRO for Your Clinical Trial Monitoring

    At Altasciences, we understand your clinical trials are unique and require careful management. As part of our partnership with you, our highly experienced CRAs offer top quality monitoring, through agile and flexible processes and transparent communication. We are up to date with all required trainings, and remain abreast of current legislations, techniques, and technologies.

    For more information on Altasciences' monitoring capabilities, contact one of our experienced CRA team members.

    Contact CRA expert

    The Right Strategy for your Small Molecule Program

    Did you know that, in addition to large molecule work, Altasciences' preclinical team has extensive experience in designing and conducting safety assessment programs for small molecules? Our solutions meet all regulatory requirements, and include IND/NDA-enabling toxicology, safety pharmacology, and laboratory services in both rodent and non-rodent species.

    Choose Altasciences for your small molecule safety assessment program and let us guide you seamlessly through each milestone.

    Polyvalent Human Immune Globulin: A Prospective, Open-Label Study Assessing Anti-Hepatitis A Virus (HAV) Antibody Levels, Pharmacokinetics, and Safety in HAV-Seronegative Healthy Subjects

    Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy

    Subscribe to Clinical Trials